N UCLEAR EVENTS INDUCED by TGF-␤ gene family
members occur through multiple intracellular mediators (1, 2) . In vitro studies reveal that certain transcription factors interact directly with members of one group of these mediators, termed Smads. This interaction appears to integrate and focus signals generated by TGF-␤ or activin-A in specific ways (3) (4) (5) . A consensus DNA sequence, 5Ј-AATC-CACA-3Ј, binds two forkhead transcription factors, expressed during early embryogenesis and designated as FAST proteins, that act in this manner (3, 4) . This sequence differs only slightly from a strong DNA binding sequence, 5Ј-XAACCACA-3Ј, for members of the Runt homology domain transcription factor family (AML, CBFa, PEBP2), now termed Runx factors (6) . These similarities suggest that transcriptional effects currently ascribed to either a FAST or a Runx protein might also be regulated under conditions where a member of the other nuclear factor gene family is preferentially expressed.
In bone, the Runx isoform Runx2 (previously termed CBFa1) controls the expression of several genes associated with differentiated osteoblasts (7) (8) (9) (10) (11) (12) . In this regard, the TGF-␤ type I receptor (T␤RI), whose gene promoter contains several Runx binding sites (9, 13) , is retained on differentiated osteoblasts when other T␤R levels decline (14) . Forced expression of Runx protein enhances T␤RI gene promoter activity in undifferentiated bone cells (13) . Furthermore, loss of Runx2 by exposure to high levels of glucocorticoid reduces T␤RI expression by fetal rat osteoblasts, and in so doing, suppresses TGF-␤-dependent biochemical effects (9) .
Due to strong similarities between the cognate Runx and FAST binding sequences, Runx may therefore bind to both cis-acting elements in cells like osteoblasts that express preferentially high levels of Runx protein. In these cases, Runxdependent genes may be controlled in appropriate ways, whereas the expression of genes that require FAST protein complexes may be either induced or disrupted. Similarly, and independently of its own cognate effects, high levels of FAST may interact directly with Runx cis-acting elements, or may indirectly regulate TGF-␤ activity through changes in Runx-dependent T␤RI expression. In this study, we assessed whether variations in the expression of Runx2 and FAST-1 alter gene expression directed by their individual cis-acting elements in differentiated osteoblasts, where an abundance of Runx2 preexists. Because Runx2 regulates T␤RI expression by these cells, we also examined whether a high level of FAST-1 alters T␤RI gene promoter activity and TGF-␤-dependent gene expression in these cells. Our results provide a new example of how nuclear events induced by TGF-␤ may rely on contextual changes in transcription factors during specific developmental states or within individual tissue lineages.
ing the initial collagenase digestion interval (13, 14, 18, 19) . Cells were plated at 4,000/cm 2 in DMEM supplemented with 10% FBS (Life Technologies, Inc.). COS-7 (CRL 1651) and LLC-PK 1 (CRL1392), obtained from the ATCC (Manassas, VA), were plated at 10,000/cm 2 in identical culture medium.
Transfection constructs
Reporter plasmids SBE4, SBE, FBE, and FSBE, which contain Smad, FAST, or composite FAST/Smad binding elements (3, 20) , and an expression construct encoding the human FAST-1 gene (3), were obtained from Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD). Reporter plasmid 3TPLux, which contains three AP1-related response elements and a minimal fragment of the plasminogen activator inhibitor 1 gene promoter and is highly sensitive to stimulation by TGF-␤ in many cells, including in primary osteoblast cultures (9, 20 -22) , was obtained from Dr. Joan Massague (Memorial Sloan-Kettering Cancer Center, New York, NY). Reporter plasmid ARE, which contains a FAST-dependent TGF-␤ response element within the context of a Mix.2 gene promoter fragment (23) was obtained from Dr. Malcolm Whitman (Harvard University, Boston, MA). Reporter plasmids pSXN1C, with two Runx binding elements (9, 13) , pT␤RI/0.4, with three Runx binding elements within the context of a rat T␤RI gene promoter fragment (13) , and expression constructs encoding murine Runx2 (initially designated as PEBP2-␣A1) (24) were described previously. Antisense to Runx2 was produced by ligating a 2.25-kb restriction fragment of the murine gene in reversed orientation into vector pSV7d. For some studies, full-length FAST-1 in vector pcDNA3 (Invitrogen) was modified to include a carboxyl-terminal hemophilus influenza hemagglutinin (HA) epitope tag.
Transfections
Promoter/reporter or gene expression plasmid constructs, or empty vectors that were pretitrated for optimal expression efficiency, were transfected using LT1 (Mirus Corp., Madison, WI). Briefly, cultures at 50 -70% confluence were exposed to plasmids for 16 h in serum-depleted medium, and supplemented to obtain a final concentration of 5% serum. For reporter gene assays, cultures were expanded for 48 h, treated in serum-free medium, rinsed, and lysed. Nuclear-free supernatants were analyzed for reporter gene activity and corrected for protein content. To account for competition among plasmids for limiting transcriptional components, control cultures were transfected with equivalent amounts of empty expression vectors. Transfection efficiency was assessed in parallel in cells transfected with positive and negative reporter plasmids, as in previous studies (9, 13) .
Cytoplasmic and nuclear protein extracts
Cells were rinsed, harvested by scraping and centrifugation, and lysed in hypotonic buffer supplemented with phosphatase and protease inhibitors and 1% Triton X-100. Nuclei and cytoplasm were separated by centrifugation. Nuclei were resuspended in hypertonic buffer with glycerol and phosphatase and protease inhibitors. Released nuclear proteins were separated from insoluble material by centrifugation (9, 13) .
Western blot analysis
Cell extracts were fractionated by electrophoresis on a 12% SDS polyacrylamide gel, blotted onto Immobilon P membranes (Millipore Corp., Bedford, MA), probed with antibody to Runx2, T␤RI or T␤RII, and visualized with secondary antibody, ECL reagents (Amersham Pharmacia Biotech, Piscataway, NJ) and chemiluminescence (9, 13, 25) .
EMSA
Commercial double-stranded DNA probes ( 
Collagen and noncollagen protein synthesis
Cells were pulsed with 5 Ci/ml [2,3- 3 H]proline (2.5 Ci/mmol; NEN Life Science Products, Boston, MA) for the last 2 h of culture. Cell layers were lysed by freeze-thawing, extracted in 0.5% Triton X-100 (Sigma, St. Louis, MO), precipitated with 10% trichloroacetic acid, chilled, and acid-precipitated material was collected by centrifugation. Precipitates were acetone extracted, dried, resolubilized in 0.5 n acetic acid, and neutralized with NaOH. [ 3 H]Proline incorporation into collagen and noncollagen protein pools were measured with bacterial collagenase (Worthington, Lakewood, NJ) free of nonspecific protease activity (14, 15) .
Reagents
Recombinant TGF-␤1 identical in sequence to human TGF-␤1 was used in collaboration with Bristol-Myers Squibb Co. (Seattle, WA). Antiserum directed against human Runx2 (initially designated AML-3) was generously provided by Dr. Scott W. Hiebert (Vanderbilt University, Nashville, TN) (25) . Nonimmune rabbit serum and antibodies directed against T␤RI, T␤RII, and HA were from Santa Cruz Biotechnologies (Santa Cruz, CA).
Statistical analysis
Statistical differences were assessed by one-way ANOVA, and the Student's-Newman-Keuls method was used for post hoc analysis, with SigmaStat software (Jandel Corp., San Rafael, CA). A significant difference was assumed by a P value of Ͻ0.05.
Results

TGF-␤-dependent gene promoter usage in osteoblasts
Basal gene expression directed by the promoter/reporter transfection construct SBE4 (Fig. 1A) , which contains four Smad binding elements, is relatively high in untreated osteoblasts by comparison to constructs SBE, FBE, or FSBE (Fig.  1B) , which contain single Smad or FAST DNA binding elements, or composite FAST and Smad binding elements, respectively (see Table 1 ). Basal gene expression by the pro- moter/reporter construct 3TPLux (Fig. 1C) , which contains three AP1 binding elements and a minimal fragment of the plasminogen activator inhibitor promoter and is a widely used indicator of TGF-␤-dependent gene expression (9, 20 -22) , is also relatively low in osteoblasts. A maximally effective amount of TGF-␤1 induced a 2-fold increase in gene expression by SBE4 (Fig. 1A ) and a 20-fold increase by 3TPLux (Fig. 1C ). Although gene expression by 3TPLux increases in osteoblasts in response to growth regulators that activate protein kinase C, the extent and duration of reporter expression by these factors is limited by comparison to treatment with TGF-␤ (data not shown). However, similar to results in transformed colon and keratinocyte cell cultures (3-5), TGF-␤1 did not significantly affect the activity of the gene reporter constructs SBE or FBE in osteoblasts. In contrast to those systems, however, TGF-␤ induced a 2-fold increase in FSBE gene promoter activity without the need to express FAST-1 transgenically (Fig. 1B) . Therefore, transacting factors that use Smad, or combined Smad and FAST binding elements are present in differentiated osteoblasts, but appear surprisingly limited in their ability to respond to TGF-␤ by comparison to the transcriptional factors that drive gene promoter activity by 3TPLux. In analogous studies in LLC-PK 1 porcine kidney cells (ATCC CRL 1392), each reporter plasmid construct propagated a similar relative basal activity. However, TGF-␤1 induced a more striking 10-to 20-fold stimulatory effect on reporter gene expression by SBE4 and had virtually no effect on FSBE activity (data not shown).
Suppression of Runx2 expression enhances FAST-dependent gene promoter activity
DNA binding sequences for Runx transcription factors, which are highly expressed by differentiated osteoblasts (6, 13) , vary only minimally from those found in the DNA binding domains for forkhead factors FAST-1 and FAST-2 (3-5) ( Table 2) . Consequently, an abundance of Runx2 in osteoblasts could possibly affect the ability of FAST proteins to promote a high level of gene expression through FASTdependent cis-acting elements. Transfection of osteoblasts with a Runx2 antisense expression construct generated a fibroblast-like appearance that persisted in confluent cultures ( Fig. 2A) . Furthermore, Runx2 protein was decreased by 80 -85%, and gene expression directed by SXN1C, a synthetic promoter/reporter plasmid with two tandem Runx binding sites was suppressed by 75% (Fig. 2, B and C) . Therefore, transfection with the Runx2 antisense construct engendered a more fibroblast-like cellular morphology, suppressed Runx2 protein expression, and reduced Runxdependent gene expression. These features are consistent with results obtained with undifferentiated fetal rat calvarial cell cultures that endogenously express low levels of Runx2 (7) (8) (9) (10) (11) (12) . In direct contrast to these inhibitory effects, the relatively low stimulatory effect of TGF-␤1 on gene expression through promoter/reporter construct FSBE was increased to as much as 9-to 10-fold in Runx-2 antisense transfected cells (Fig. 2D) . Moreover, when osteoblasts were transfected with an expression construct to increase rather than to suppress Runx2 synthesis, the stimulatory effect of TGF-␤ on FSBE gene promoter activity was suppressed (Fig. 2E) . Similar results occurred with promoter/reporter construct ARE, which contains a related FAST-dependent TGF-␤ response element that acts within the context of a native Mix.2 gene promoter DNA fragment (5) (Fig. 2F) . Therefore, although endogenous Runx2 can enhance Runx-dependent gene expression in osteoblasts, it limits FAST-dependent gene expression through either synthetic or native gene promoter sequences.
Runx and Fast DNA binding complexes
We then examined whether FAST-dependent gene expression in osteoblasts was limited by competition between Runx2 and FAST for their closely related DNA binding elements. Nuclear extract from osteoblasts and radiolabeled probe with a Runx binding sequence from the TGF-␤RI promoter form a complex that is sensitive to anti-Runx2 antibody (9, 13). Formation of this complex, designated R, was reduced by the addition of unlabeled DNA probes containing sequences that can bind either Runx or FAST proteins (Fig. 3A) . In addition, nuclear extract from osteoblasts or from COS-7 cells transfected to express Runx2 formed complex R when combined with radiolabeled probe containing a consensus FAST binding sequence (Fig. 3B) .
Small amounts of other, more rapidly migrating complexes designated F and N, occurred with extract from Runx2 transfected COS cells and FAST probe. In contrast, extract from FAST-1 transfected COS cells predominantly formed complex F with radiolabeled FAST probe, but virtually no complex F with radiolabeled Runx probe. Because low levels of complex F occurred with extract from Runx transfected COS cells and low levels of complex R occurred with extract from FAST-1 transfected COS cells, small amounts of each protein are endogenous to the COS cells themselves. Nevertheless, complex R was always sensitive to dilution by unlabeled Runx or FAST probes, whereas complex F, which formed with extract from FAST-1 transfected COS cells and the FAST probe, was preferentially sensitive to unlabeled FAST probe. Competition for complex N occurred with both Runx and Fast consensus probes. Like complex F, however, N was more sensitive to the FAST binding sequence when it was formed by extract from FAST-1 transfected COS cells (Fig. 3B) . The identity of factors in complex N is still uncertain.
To assess whether Runx2 could still interact with the FAST consensus sequence in the presence of high levels of FAST-1, nuclear extract was prepared from COS cells transfected to express both Runx2 and HA-tagged FAST-1. Complex R formed with the FAST consensus probe was specifically reduced by anti-Runx2 antibody, whereas a fourth complex (designated HA-F) was reduced by anti-HA antibody (Fig.  3C) . However, consistent with little or no binding by FAST-1 to RUNX consensus sequences, no anti-HA antibody reactive complex formed with this extract and Runx2 probe (data not shown). Therefore, Runx2 can bind to both the FAST and Runx consensus DNA sequences to form complex R, and FAST-1 predominantly binds the FAST consensus sequence to form complex F.
Loss of Runx2 limits T␤RI expression and TGF-␤ activity in osteoblasts
Consistent with multiple Runx binding sites in the T␤RI gene promoter and high levels of Runx2 in osteoblasts, transfection with the Runx2 antisense expression construct dose dependently decreased T␤RI gene promoter activity in these cells. Runx2 antisense expression also specifically decreased the amount of T␤RI protein in these cells, whereas it had no effect on T␤RII (Fig. 4, A and B) . Loss of Runx2 in this way did not alter basal collagen synthesis in untreated cultures (102 Ϯ 9% of control). However, in agreement with its ability to reduce T␤RI synthesis, expression of Runx2 antisense limited the stimulatory effect of TGF-␤ on collagen synthesis as well as on gene expression through the promoter/reporter construct 3TPLux (Figs. 4, C and D) .
FAST-1 limits Runx-dependent gene expression and TGF-␤ activity in osteoblasts
Because Runx2 bound FAST binding sequence and FAST-1 formed little if any complex F with Runx binding sequence, transcriptional complex formation appears less promiscuous at Runx cis-acting elements (Fig. 3) . Nevertheless, forced expression of FAST-1 reduced reporter gene expression by the synthetic Runx-sensitive promoter/reporter plasmid SXN1C (Fig. 5A) . Consistent with multiple Runx binding elements in the T␤RI gene promoter, forced expression of FAST-1 reduced gene expression directed by the T␤RI gene promoter plasmid (Fig. 5B) . Furthermore, because of the essential role of T␤RI for TGF-␤ activity, it also reduced downstream effects by TGF-␤ on 3TPLux reporter gene expression (Fig. 5C) , and on collagen (Fig. 5D ) and noncollagen (Fig. 5E ) protein synthesis.
Unlike results in cells derived from other tissues (3-5), overexpression of FAST-1 did not further enhance basal or TGF-␤1-induced gene expression by combined FAST and Smad binding transcriptional elements in osteoblasts. Moreover, the significant increase in gene expression through promoter/reporter construct FSBE that occurred in osteoblasts by disruption of Runx2 synthesis was also suppressed by forced expression of FAST-1 (Fig. 5F ). Together, these results suggest that high levels of FAST-1 interfere with Runx-dependent gene expression independently of effects on DNA binding, and can minimize TGF-␤ activity in osteoblasts by a direct inhibitory effect on T␤RI expression.
Discussion
TGF-␤ produces diverse effects on gene expression that relate to tissue and cell specificity and to cellular differentiation status. This is thought to require different or different combinations of intracellular effectors and transcription factor complexes (1) (2) (3) . In this study, we provide new evidence for counter-regulatory effects by members of two transcription factor gene families, FAST and Runx, previously associated with discrete aspects of TGF-␤ activity. Links between these factors occur in part through competition for a common transcriptional element, and in part through changes in T␤RI expression. We found that FAST-dependent gene expression was minimal in cells where high levels of Runx2 preexist, and that Runx2 effectively competed for and associated with a consensus FAST binding sequence. We also found that forced expression of FAST-1 could decrease Runx2 activity. In this case, however, FAST-1 did not compete for consensus Runx binding sequences, although it limited T␤RI gene promoter activity in osteoblasts and suppressed downstream effects by TGF-␤ treatment. Therefore, effects by FAST-1 appeared focused on other elements required for Runx transcriptional activity. A model for these events is shown in Fig. 6 .
Runx2 is considered an essential component of differential gene expression by osteoblasts. Transfection with a Runx2 antisense expression construct caused osteoblasts to assume a more fibroblast-like morphology in vitro and appropriately reduced Runx-dependent gene expression. Consistent with the presence of multiple Runx binding elements in the rat ⌻␤RI gene promoter (13) , loss of Runx2 reduced ⌻␤RI expression as well as some aspects of ⌻GF-␤ activity. Nevertheless, in this context the stimulatory effect of TGF-␤ on FAST-dependent gene expression was significantly increased. Therefore, expression of Runx-2 antisense was not toxic or nonspecific in fetal rat osteoblasts, and the downstream components required for FAST activity exist and were better used, even though these cells also exhibited a reduced level of T␤RI.
Runx was either more abundant in osteoblast-derived extracts, or exhibited a higher DNA binding affinity relative to FAST protein, when tested with either Runx or FAST consensus binding sequences. We were only able to assess the presence of endogenous FAST in fetal rat osteoblasts by its functional effects on gene expression with synthetic and native promoter fragments, because crossreactive antibody to rat FAST protein was unavailable for our studies (Malcolm Whitman, Harvard University; personal communication). However, recombinant FAST-1 prepared from transfected COS-7 cells readily associated with a consensus FAST binding sequence, but bound only poorly to a Runx consensus element. We earlier showed that oligonucleotide with an A to T substitution, positioned as it occurs in the FAST binding sequence used here, effectively competed for complex formation by two radiolabeled consensus Runx probes (13) . Therefore, stimulatory effects by FAST may be focused to a more limited set of gene promoters by comparison to the growing number now associated with Runx proteins. In this regard, the slightly different FAST binding sequence that occurs in the Mix.2 gene promoter (5), where a single nucleotide difference disrupts the Runx binding core, also shows minimal activity in osteoblasts. Moreover, in initial studies we found that treatment with bone morphogenetic protein 2, which increases Runx2 expression by osteoblasts, sup- presses Mix.2 gene promoter activity in osteoblasts, whereas TGF-␤ does not (unpublished results). Nevertheless, forced expression of FAST-1 did not overcome the inhibitory effect of Runx on FAST-dependent gene expression, but suppressed Runx-dependent gene expression by osteoblasts. Importantly, FAST and Runx family members each directly associate with specific Smads to integrate the expression of genes induced by various TGF-␤ gene family members (1-5, 26 -28) . Therefore, FAST appears to suppress Runx-dependent gene expression as well as some aspects of TGF-␤ activity in osteoblasts by competition for a limiting level of Smads. Alternately, at sufficiently high levels, FAST proteins may bind to and directly suppress Runx activity. We are now assessing whether the ability of these factors to compete in restricted ways for common and discrete genomic elements or transcription integrators, or to form complexes between themselves, distinguishes direct stimulatory effects on some gene promoters and indirect inhibitory effects on others.
In summary, our study provides new examples of mechanisms to account for restricted gene expression in response to TGF-␤ treatment. Some occur at the level of transcription factor expression, some on competition between factors for common transcription elements, and some on downstream effects on T␤RI expression. A better understanding of the interactions between FAST and Runx gene family members for common cis-and trans-acting genomic elements, and the relatively tissue-restricted expression of Runx proteins by hematopoietic and skeletal cells, may help to define transitional effects by TGF-␤ during development and tissue specification. By contrast, FAST does not compete well for binding at Runx-specific cis-acting elements, whereas at sufficiently high levels it can compete with Runx for Smads and thereby suppress Runx-dependent gene expression. In this way, it also decreases T␤RI synthesis and reduces TGF-␤ activity in these cells, where Runx helps to maintain a high level of T␤RI.
